Iradimed (IRMD) Accounts Payables (2013 - 2026)

Iradimed (IRMD) has 14 years of Accounts Payables data on file, last reported at $2.2 million in Q1 2026.

• Accounts Payables for Q1 2026 came in at $2.2 million, down 15.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (down 15.75% YoY), and the FY2025 annual result was $1.8 million, down 4.01% from the prior year.
• Accounts Payables grew to $2.2 million in Q1 2026 per IRMD's latest filing, from $1.8 million in the prior quarter.
• Over five years, Accounts Payables peaked at $2.8 million in Q3 2023 and troughed at $822118.0 in Q2 2022.
• A 5-year average of $1.8 million and a median of $1.8 million in 2025 frame the typical range for Accounts Payables.
• The sharpest annual moves came in 2023 and 2024: Accounts Payables soared 210.43% in 2023, then plunged 56.07% in 2024.
• A 5-year view of Accounts Payables shows it stood at $1.8 million in 2022, then advanced by 3.21% to $1.9 million in 2023, then climbed by 2.1% to $1.9 million in 2024, then retreated by 4.01% to $1.8 million in 2025, then climbed by 19.89% to $2.2 million in 2026.
• Business Quant data shows IRMD's Accounts Payables at $2.2 million in Q1 2026, $1.8 million in Q4 2025, and $2.3 million in Q3 2025.